These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
141 related items for PubMed ID: 7487092
21. Heme and apoprotein modification of cytochrome P450 2B4 during its oxidative inactivation in monooxygenase reconstituted system. Karuzina II, Zgoda VG, Kuznetsova GP, Samenkova NF, Archakov AI. Free Radic Biol Med; 1999 Mar; 26(5-6):620-32. PubMed ID: 10218650 [Abstract] [Full Text] [Related]
22. Mechanism-based inactivation of cytochrome P450 2B1 by 7-ethynylcoumarin: verification of apo-P450 adduction by electrospray ion trap mass spectrometry. Regal KA, Schrag ML, Kent UM, Wienkers LC, Hollenberg PF. Chem Res Toxicol; 2000 Apr; 13(4):262-70. PubMed ID: 10775326 [Abstract] [Full Text] [Related]
23. [Self-inactivation of cytochrome P-450 2B4 during catalytic cycle in the monooxygenase reconstituted system]. Zgoda VG, Karuzina II, Archakov AI. Vopr Med Khim; 1997 Apr; 43(4):217-25. PubMed ID: 9312936 [Abstract] [Full Text] [Related]
29. Cytochrome P450 2B1-mediated one-electron reduction of adriamycin: a study with rat liver microsomes and purified enzymes. Goeptar AR, Te Koppele JM, Lamme EK, Piqué JM, Vermeulen NP. Mol Pharmacol; 1993 Dec; 44(6):1267-77. PubMed ID: 8264564 [Abstract] [Full Text] [Related]
30. Escherichia coli expression of site-directed mutants of cytochrome P450 2B1 from six substrate recognition sites: substrate specificity and inhibitor selectivity studies. He YQ, He YA, Halpert JR. Chem Res Toxicol; 1995 Jun; 8(4):574-9. PubMed ID: 7548737 [Abstract] [Full Text] [Related]
31. On the mechanism of the inactivation of the major phenobarbital-inducible isozyme of rat liver cytochrome P-450 by chloramphenicol. Halpert JR, Miller NE, Gorsky LD. J Biol Chem; 1985 Jul 15; 260(14):8397-403. PubMed ID: 3924914 [Abstract] [Full Text] [Related]
32. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen. Koenigs LL, Peter RM, Thompson SJ, Rettie AE, Trager WF. Drug Metab Dispos; 1997 Dec 15; 25(12):1407-15. PubMed ID: 9394031 [Abstract] [Full Text] [Related]
36. Cytochrome b5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4. Zhang H, Im SC, Waskell L. J Biol Chem; 2007 Oct 12; 282(41):29766-76. PubMed ID: 17693640 [Abstract] [Full Text] [Related]
37. One-electron reductive bioactivation of 2,3,5,6-tetramethylbenzoquinone by cytochrome P450. Goeptar AR, te Koppele JM, van Maanen JM, Zoetemelk CE, Vermeulen NP. Biochem Pharmacol; 1992 Jan 22; 43(2):343-52. PubMed ID: 1310854 [Abstract] [Full Text] [Related]
38. P450 enzyme CYP2B catalyzes the detoxification of diisopropyl fluorophosphate. Laaksonen M, Kaliste-Korhonen E, Kärenlampi S, Hänninen O. Chem Biol Interact; 1995 Mar 18; 94(3):197-213. PubMed ID: 7820884 [Abstract] [Full Text] [Related]
39. Interaction between cytochrome P450 2B1 and cytochrome bs: inhibition by synthetic peptides indicates a role for P450 residues Lys-122 and Arg-125. Omata Y, Sakamoto H, Robinson RC, Pincus MR, Friedman FK. Biochem Biophys Res Commun; 1994 Jun 30; 201(3):1090-5. PubMed ID: 8024550 [Abstract] [Full Text] [Related]
40. Determinants of protein modification versus heme alkylation: inactivation of cytochrome P450 1A1 by 1-ethynylpyrene and phenylacetylene. Chan WK, Sui Z, Ortiz de Montellano PR. Chem Res Toxicol; 1993 Jun 30; 6(1):38-45. PubMed ID: 8448348 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]